Popular Articles

Positive Results From Salix Pivotal Phase III Study Of Rifaximin For The Prevention And Maintenance Of Remission Of Hepatic Encephalopathy (HE)
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced on Monday the presentation of new data from its Phase III pivotal clinical trial evaluating the efficacy, safety and tolerability of rifaximin - a non-absorbed (O144. The Effect of Prognostic Factors on the Maintenance of Remission in Hepatic Encephalopathy Patients Treated with Rifaximin

New Location Found For Regulation Of RNA Fate
Thousands of scientists and hundreds of software programmers studying the process by which RNA inside cells normally degrades may soon broaden their focus significantly.
News of the day
Patients And Health Care Providers Seek Improved Quality As Report Shows Extensive Errors
The Washington Post reports on efforts by hospitals to tally their avoidable mistakes and describes "hundreds of incidents of death or serious medical harm disclosed in the past year by hospitals in the Washington region, preventable errors that until recently have not required public reporting. Under laws that took effect last year in Virginia and a few years earlier in the District and Maryland, hospitals must report to health regulators many serious injuries that patients suffer in the course of treatment. The laws are different in each jurisdiction. For example, Virginia"s public records identify the hospitals by name, while Maryland"s and the District"s do not. But they all allow the public to glimpse the breadth of mistakes that health experts dub "never events" (because they should never happen): sponges left inside patients after surgery, operations on the wrong limb, medication errors, falls that lead to needless deaths (as well as other events). At least 20 states require hospitals to report every incidence of hospital-acquired infection. Patients, insurers and regulators are beginning to use this information to prod health-care providers to ensure that such events really never happen."
Diagnostics

Lords Science Committee To Publish Follow-Up Report On Flu, UK

The House of Lords Science and Technology Committee will next week publish a short report on UK preparedness and pandemic influenza. The report follows a short inquiry which began in November 2008. It was initially intended as a follow-up to the Committee"s 2005 report on pandemic flu when H5N1 or avian flu was thought to pose the greatest risk to public health. With the spread of the H1N1 virus or swine flu, the Committee shifted its focus to the Government"s response to the current outbreak and considers emerging issues in the light of this test of UK preparedness. The report will be published at 10:00am on Tuesday 28 July. Hard copies of the report: * Can be collected by journalists* from the reception of 2 Millbank House, House of Lords, London, SW1P 3LX from 10:00 on Tuesday 28 July * Will be available in the Parliamentary Press Gallery from 10:00 on Tuesday 28 July. The House of Lords Science


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):